Baseline characteristics of the 56 patients of the study
| Characteristics | Value |
|---|---|
| Age (yr) (median) (Q1–Q3) | 54 (46–66) |
| Female (No.) (%) | 51 (92) |
| Vascular risk factor (No.) (%) | 31 (55) |
| Antiaggregation platelet therapy (No.) (%) | 15 (27) |
| Asymptomatic (No.) (%) | 4 (7) |
| Pain (No.) (%) | 43 (77) |
| Cranial nerve palsy (No.) (%) | 40 (72) |
| SAH or CCF (No.) (%) | 4 (7) |
| Giant saccular aneurysms (≥25 mm) (No.) (%) | 27 (48) |
| Large saccular aneurysms (≥15 mm, <25) (No.) (%) | 24 (43) |
| Fusiform aneurysms (No.) (%) | 5 (9) |
| Infraclinoid aneurysms (No.) (%) | 42 (75) |
| Mural thrombus (No.) (%) | 15 (27) |
| Multiple aneurysms (No.) (%) | 11 (20) |
| Timing of BOT ≥2 sec (No.) (%) | 7 (13) |
| General anesthesia (No.) (%) | 16 (28) |
Note:—CCF indicates carotid cavernous fistula.